Fei Ling

Title: Fei Ling - Innovator in Drug Synthesis

Introduction

Fei Ling is a notable inventor based in Jiaxing, China. He has made significant contributions to the field of drug synthesis, particularly through his innovative methods in preparing pharmaceutical intermediates. His work has implications for the development of new drugs and improving existing synthesis processes.

Latest Patents

Fei Ling holds a patent for a method titled "Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone." This patent describes a novel approach to synthesizing trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, which is crucial for the production of halofuginone. The method utilizes amino-substituted pentanal and a thiazolyl sulfoxide compound as raw materials, employing Mislow-Evans rearrangement reaction and subsequent Lewis acid catalysis. This innovative technique achieves high yields and stable qualities, providing a new reference route for synthesis while avoiding the use of expensive metal catalysts.

Career Highlights

Fei Ling is currently employed at Chengda Pharmaceuticals Co., Ltd., where he continues to advance his research in drug synthesis. His work has garnered attention for its potential to streamline pharmaceutical production processes and enhance the efficiency of drug development.

Collaborations

Fei Ling collaborates with talented coworkers, including Yu Feng and Hong Xu. Their combined expertise contributes to the innovative environment at Chengda Pharmaceuticals Co., Ltd.

Conclusion

Fei Ling's contributions to drug synthesis through his patented methods highlight his role as an influential inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also paves the way for more efficient drug production methods.